GazePoint is revolutionary technology designed to quickly simplify the detection, and management of individuals with neurologic disorders or impairments affecting the neurologic system. These disorders can be concussions, Alzheimer’s Disease or other diseases as well as impairments related to fatigue, substance use and many other causes. Combining advanced software technology embedded in head-worn devices offers accuracy, convenience, and peace of mind in detecting these disorders early. This proven software technology can be embedded in virtual, augmented, and mixed reality devices, as well as faceguards. Knowing an impairment exists, when using these devices, provides early treatment to prevent permanent and functional disabilities.
Dr. Krueger is a medical professional and inventor with over four decades of expertise in otolaryngology, neurotology, and skull base surgery, complemented by groundbreaking contributions to eye-tracking technology. Board-certified in Otolaryngology–Head & Neck Surgery and Neurotology, Dr. Krueger has a robust academic and clinical background, including an M.D. from The University of Texas Medical School (1975), a fellowship in Otology/Neurotology at the House Ear Institute/Clinic), and advanced training in digital health strategy from Columbia Business School. His extensive experience in head trauma and concussion management, coupled with unique real-world exposure to spatial disorientation, underpins his innovative work in developing patented eye-tracking technologies. Dr. Krueger’s expertise in head trauma and skull base disorders stems from over 40 years of surgical practice, operating on thousands of patients with neurotologic/skull base disorders and directing a concussion clinic. His firsthand experience with spatial disorientation came from flying in military aircraft and serving as a life-flight surgeon in helicopters, during his early career, performing life-saving interventions under high-stress conditions. These experiences informed his research into vestibular and ocular dysfunction, particularly in high-performance environments like aviation and sports.
Key Innovations
Concussion Detection:
Targets 37–45 million U.S. and 960 million–1 billion global contact sport participants. Embedded in faceguards for 3.3 million U.S. and 6 million+ global players in faceguard-required sports (e.g., football, hockey), it prevents secondary concussions and permanent injury. Sideline VR/AR devices assess all contact sport players, while emergency centers, urgent care, and rehab facilities use AR/VR for TBI monitoring and return-to-play decisions. With 5–60 million annual non-sport TBIs (e.g., falls, assaults), this application is broadly applicable.
Eye Movement Measurement:
Enhances performance and detects dysfunction across industries (medical, sports, defense field operations, commercial roles like air traffic control, bus/auto/aircraft operation, assembly plants, oil fields, law enforcement), with immediate rehabilitation capabilities.
Motion Sickness Mitigation:
VR/AR platforms for aviation, gaming, and military, validated by NIH SBIR grants.
Human Performance Prediction:
Ocular analysis for high-stakes environments (sports, aerospace, assembly, rockets, defense, medicine, legal tasks with critical equipment or people).
Helmet and Padding Innovations:
Sensor-equipped gear to mitigate brain injury in sports, defense, and commercial settings.
Substance Use Assessment:
3-minute daily checks for truck drivers, critical component assemblers, and legal/law enforcement, reducing $74B in annual accident costs. Applicable for pre-employment, random, or daily performance checks across all industries.
Immediate Visual Rehabilitation:
Supports post-abnormality recovery for DoD special ops, athletes, non-sport TBI patients, and pharmaceutical therapy assessment, cutting recovery costs by $1M per case.
Pharmaceutical Efficacy:
Accurately assesses drug therapy effectiveness for neurologic disorders by tracking eye movements (e.g., smooth pursuit, saccades) affecting brain function layers.
CNS Disorder Efficacy:
Uses eye movement assessment (smooth pursuit, saccades, VOR, VOR suppression, vergence, pupil responses, eye blinks) for cheaper, objective, rapid, and accurate evaluation of CNS-affecting drug therapies.
Patent Summaries and Application Opportunities
This patent covers a system and method using eye-tracking and head-worn displays to mitigate spatial disorientation, likely involving VR/AR platforms to stabilize visual input for pilots or users in high-motion environments.
Potential Applications:
Defense: Enhances pilot safety in Air Force and Navy aviation, reducing $1B+ crash risks (licensing $50M–$80M).
Commercial: Improves VR gaming and simulator training (e.g., flight schools), with $30M–$50M licensing potential.
Medical: Supports vestibular rehab for disorientation disorders, adding $25M–$40M.
Describes a biosensor system using eye-tracking to monitor physiologic states (e.g., fatigue) and control vehicles or equipment, likely via head-worn devices.
Potential Applications:
Defense: Controls military vehicles/drone interfaces for special ops ($50M–$70M).
Commercial: Monitors truck drivers and heavy machinery operators, reducing $74B in accidents ($40M–$60M licensing).
Medical: Assesses operator fitness in medical transport, adding $25M–$40M.
Extends vehicle/device control based on human ocular performance metrics, likely building on biosensor data for real-time response.
Potential Applications:
Defense: Improves combat vehicle operation ($50M–$70M).
Commercial: Enhances autonomous vehicle safety (e.g., Tesla), with $40M–$60M licensing.
Sports: Adjusts training equipment based on performance ($20M–$30M).
Involves eye-tracking within a faceguard to measure head impacts and detect concussions in real-time, integrated into sports equipment.
Potential Applications:
Defense: Adapts for combat helmets in special ops ($50M–$70M).
Sports: Revolutionizes concussion detection in football/hockey (e.g., NFL, NHL), with $50M–$80M licensing per league.
Medicine: Supports clinical concussion assessment, adding $30M–$50M.
A continuation or enhancement of US10,602,927, refining faceguard-based concussion detection with improved ocular metrics.
Potential Applications:
Same as US10,602,927, with potential for higher licensing ($60M–$80M) due to enhanced accuracy.
Describes a mechanical/fluid system using eye-tracking to prevent motion sickness, likely via head-worn or VR devices.
Potential Applications:Defense: Mitigates motion sickness in naval/military transport ($50M–$70M).
Commercial: Enhances VR gaming and automotive comfort (e.g., self-driving cars), with $30M–$50M licensing.
Medicine: Treats motion sickness disorders, adding $25M–$40M.
An improvement or continuation of US9,080,868, optimizing motion sickness prevention with fluid dynamics.
Potential Applications: Same as US9,080,868, with potential for $40M–$60M licensing due to advancements.
Focuses on detecting rotational head impacts (e.g., whiplash) using faceguard eye-tracking, expanding concussion assessment.
Potential Applications:
Sports: Targets rugby/soccer, with $50M–$70M licensing.
Defense: Assesses blast injuries in combat ($50M–$70M).
Medicine: Improves TBI diagnosis, adding $30M–$50M.
Adapts faceguard technology to face shields, broadening concussion detection to non-contact sports or industrial use.
Potential Applications:
Sports: Extends to basketball/baseball, with $40M–$60M licensing.
Commercial: Monitors industrial workers, adding $30M–$50M.
Defense: Enhances riot gear safety ($50M–$70M).
Covers a system to reduce impact forces, likely involving padding or helmet design with sensors.
Potential Applications:Sports: Improves helmet safety in football, with $30M–$50M licensing.
Defense: Reduces soldier injury in combat ($40M–$60M).
Commercial: Enhances industrial safety gear, adding $20M–$30M.
An enhancement or continuation of US8,347,421, refining impact reduction technology.
Potential Applications:
Same as US8,347,421, with potential for $40M–$60M licensing.
Further improvement of impact reduction, possibly integrating sensors for real-time feedback.
Potential Applications:
Same as US8,347,421, with potential for $50M–$70M licensing.
Uses eye-tracking to measure VOR for performance enhancement, likely via head-worn devices.
Potential Applications:
Sports: Boosts athlete training (e.g., NFL), with $40M–$60M licensing.
Defense: Enhances pilot performance ($50M–$70M).
Medicine: Treats vestibular disorders, adding $30M–$50M.
Extends VOR measurement to VR/AR platforms for training and improvement.
Potential Applications:
Commercial: Enhances VR gaming/training, with $30M–$50M licensing.
Defense: Trains pilots/naval personnel ($50M–$70M).
Medicine: Rehabilitates vestibular patients, adding $25M–$40M.
An improvement of US9,788,714, optimizing VOR assessment in VR/AR.
Potential Applications:
Same as US9,788,714, with potential for $40M–$60M licensing.
Uses head and eye data to assess general health via ocular parameters.
Potential Applications:
Medicine: Monitors chronic conditions, with $40M–$60M licensing.
Commercial: Workplace health screening, adding $30M–$50M.
Defense: Assesses soldier fitness ($50M–$70M).
Focuses on neurologic health assessment using ocular metrics.
Potential Applications:
Medicine: Diagnoses CNS disorders, with $50M–$70M licensing.
Pharma: Evaluates CNS drug efficacy, adding $60M–$80M.
Defense: Detects TBI, adding $50M–$70M.
Integrates eye imaging into face protection (e.g., faceguards) for health assessment.
Potential Applications:
Sports: Enhances concussion detection, with $50M–$80M licensing.
Defense: Monitors combat personnel, adding $50M–$70M.
Commercial: Industrial safety, adding $30M–$50M.
Uses wearable devices (e.g., glasses) for health assessment via eye imaging.
Potential Applications:
Medicine: Monitors patients remotely, with $40M–$60M licensing.
Commercial: Workplace/substance use monitoring, adding $30M–$50M.
Defense: Assesses field personnel, adding $50M–$70M.
A continuation-in-part that broadens sensing to eye + face analytics for robust, multimodal health assessment. Designed to enhance accuracy, reduce false positives, and support real-time interventions across clinical, field, and consumer contexts.
Market Appeal
Pharmaceutical Impact:
Targets 2–3% of the $180.6B CNS market by 2030, offering $1B–$1.5B in licensing and royalties.
Sports Safety:
Faceguard and sideline applications serve 10+ global leagues, generating $200M–$300M.
DoD Strategic Value:
Enhances special ops and aviation safety, with contracts adding $400M–$600M, supported by the DoD’s $11.7B R&D budget.
Commercial Growth:
Addresses 10M+ safety-sensitive workers, with $300M–$500M from workplace safety across diverse industries.
Big Tech Alignment:
Leverages the $635.82B wearable market (2034 projection) and $50B+ annual R&D (e.g., Apple’s $26B), with $200M–$400M in licensing potential.
Valuation and Upside
Per-Patent Value:
$25M–$80M (average $52.5M), reflecting multi-sector demand and innovative applications.
Total Value:
$750M–$1.68B, with a midpoint of $1.215B.
Upside Potential:
$2.5B–$3B, driven by royalties, global expansion, and device sales across all targeted sectors.